Company / Operating Cash Flow per Share
Ginkgo Bioworks Holdings, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.15
FY2025
5-year range
-$6.39 / -$0.16
FY2021-FY2025
Trend
+50.7%
vs FY2024
Sector context
#170 of 210
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s operating cash flow per share of $-3.15 is lower than 81% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-6.39 in FY2024 to $-0.04 in FY2019.
Based on SEC 10-K filings.
-3.15 in FY2025.
Declined from $-0.16 to $-3.15 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-159.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 50.7% year-over-year.
- Ranks #170 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.15 | +50.7% |
| FY2024 | -$6.39 | -3989.7% |
| FY2023 | -$0.16 | +0.2% |
| FY2022 | -$0.16 | +20.5% |
| FY2021 | -$0.20 | -84.9% |
| FY2020 | -$0.11 | -174.1% |
| FY2019 | -$0.04 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026